Status:

NOT_YET_RECRUITING

Revisiting the Concept of Nerve Sparing Radical Hysterectomy

Lead Sponsor:

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Conditions:

Cervical Cancers

Eligibility:

FEMALE

18+ years

Brief Summary

Nerve-sparing radical hysterectomy aims to preserve the autonomic innervation of pelvic organs. In most studies, the preservation of the parasympathetic component of pelvic innervation is achieved by ...

Detailed Description

The concept of preserving pelvic autonomic innervation during radical hysterectomy was first introduced by Yabuki, who emphasized the relevance of pelvic neuroanatomy in supporting nerve-sparing techn...

Eligibility Criteria

Inclusion

  • (i) age ≥18 years; (ii) histologically confirmed cervical cancer; (iii) indication for type C1 (nerve-sparing) radical hysterectomy according to ESGO guidelines; and (iv) a minimum of 90 days of postoperative follow-up.

Exclusion

  • (i) withdrawal of consent; (ii) prior abdominal and/or pelvic surgery; (iii) pre-existing urinary incontinence, detrusor overactivity, or detrusor underactivity; and (iv) pre-existing anorectal dysfunction Staging and architectural grade were defined according to the 2018 International Federation of Gynecology and Obstetrics (FIGO) recommendations, and histological subtypes were classified based on the World Health Organization (WHO) criteria

Key Trial Info

Start Date :

June 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2027

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06999824

Start Date

June 1 2025

End Date

May 1 2027

Last Update

May 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano

Milan, Lombardy, Italy, 20148